A Population Pharmacokinetic Analysis of Nelfinavir Mesylate in Human Immunodeficiency Virus-Infected Patients Enrolled in a Phase III Clinical Trial

A population pharmacokinetic analysis was conducted on nelfinavir in patients infected with human immunodeficiency virus (HIV) who were enrolled in a phase III clinical trial. The data consisted of 509 plasma concentrations from 174 patients who received nelfinavir at a dose of 500 or 750 mg three t...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Jackson, Kimberley A., Rosenbaum, Sara E., Kerr, Bradley M., Pithavala, Yazdi K., Yuen, Geoffrey, Dudley, Michael N.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89969/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10858338/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.7.1832-1837.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!